🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kai Pollard

Human Genome Sciences (United States)

ORCID: 0000-0002-2778-8884

Also affiliated with Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression”.

CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0749
N/A
0.500DataRank · unranked
27 citations

Joshua J. Lingo, Courtney A. Kaemmer, Amanda Scherer, Akshaya Warrier, Ellen Voigt +20 more

Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors

Cancer Research(2020)10.1158/0008-5472.can-20-1992
N/A
0DataRank · unranked
47 citations

Kai Pollard, Ana Calizo, Christine A. Pratilas, Jiawan Wang

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

medRxiv(2021)10.1101/2021.09.09.21262860
N/A
0DataRank · unranked
1 citations

Christopher Douville, Natalie Silliman, Janine Ptak, Lisa Dobbyn, Joy Schaefer +10 more

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Oncogene(2022)10.1038/s41388-022-02305-x
N/A
0DataRank · unranked
41 citations

Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang +10 more

Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy

Science Advances(2022)10.1126/sciadv.abo5442
N/A
0DataRank · unranked
34 citations

Feng Zhang, Rohit Rao, Mike Adam, Kai Pollard, Sara Szabo +16 more

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

eLife(2022)10.7554/elife.74238
N/A
0DataRank · unranked
24 citations

Christopher Douville, Natalie Silliman, Janine Ptak, Lisa Dobbyn, Joy Schaefer +11 more

Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.29.490078
N/A
0DataRank · unranked
1 citations

Alex T. Larsson, Ana Calizo, Kai Pollard, Xiaochun Zhang, Eric Conniff +16 more

MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3722
N/A
0DataRank · unranked
21 citations

Neha V. Amin, Kevin He, Xiaochun Zhang, Yang Lyu, Carina Dehner +10 more

CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.02.526674
N/A
0DataRank · unranked
5 citations

Ana Calizo, Lindy Zhang, James C. Pino, Yang Lyu, Kai Pollard +11 more

Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors

Cancer Research(2020)10.1158/0008-5472.can-20-1365
N/A
0DataRank · unranked
65 citations

Kai Pollard, Amy N. Allen, Tushar Tomar, Dirk Pijnenburg, Zhan Yao +3 more

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

Molecular Medicine(2025)10.1186/s10020-025-01353-9
N/A
0DataRank · unranked
2 citations

Arnab Sarkar, Natalia García, Lindy Zhang, Ana Calizo, Alla Lisok +11 more